Abstract:‘R apid, bloody, and blinding’ are the words that Beaumont & Hollows (1972) used to classify the rare form of severe bilateral rapidly progressive proliferative diabetic retinopathy in young adults, which was later designated florid diabetic retinopathy by Kohner & Oakley (1975). Blindness was unevitable. Today, prognosis for vision in this particular group of patients is more favourable but depends entirely on early diagnosis, timely laser coagulation, and use of vitreo-retinal surgery, and yet vision can still be lost even if those measures are implemented. The purpose of this article is to describe the characteristics of florid retinopathy and to compare that condition with the much more common slowly developing type of proliferative retinopathy usually occurring in middleaged type 1 diabetic subjects. The two forms of the disease differ not only with regard to the rate of progression, but also with respect to the clinical features that are evident prior to the onset of proliferative retinopathy. It is my hope that this article can shed some light on two important issues: how to define patients who are at risk of rapid deterioration to a state of severe diabetic retinopathy that is likely to develop into florid retinopathy, and how to use our present knowledge to recognize and treat those individuals in time. It is highly possible that the current treatment paradigm will be modified in the future. Indeed, as more biochemical pathways are identified, novel therapeutic options may become available that will enable successful medical intervention at the early stages of such severe diabetic retinopathy. Comparison of the progression of florid retinopathy and slowly developing retinopathy in diabetic subjects is best achieved by considering the three representative cases described in the following. Case 1 is a 24-year-old woman who has had type 1 diabetes since she was 13 years old. She had long neglected her disease, and metabolic control was generally very poor, and during adolescence she was hospitalized for ketoacidosis several times. Also, her HbA1c values varied between 12% and 14% (reference interval 3.5–5%). As a result of substantial efforts on behalf of the diabetologist as well as the patient herself, this patient’s HbA1c levels decreased from 12.1% to 8.3% during a 3-month period. However, thereafter she stopped taking the prescribed laboratory tests for more than a year, and, when she resumed the testing 17 months after interruption, her HbA1c was 14.1%. This patient underwent annual fundus photography within our screening programme for early detection of sight-threatening diabetic retinopathy. The degree of her diabetic retinopathy had been classified as mild for a few years. However, between the last two visits for photographic screening, there had been a clear change from mild to moderate disease with haemorrhages and cotton wool spots in both eyes (Fig. 1A) and that deterioration coincided with the transiently improved metabolic control. The angiogram revealed dilated vessels (Fig. 1B) and diffuse leakage in the macular region (Fig. 1C) and in the nasal field, as well as small areas of nonperfusion (Fig. 1D). Because of the progression of the retinopathy in combination with poor metabolic control, along with the patient’s previous history of neglecting the disease, both eyes were treated with focal ⁄grid photocoagulation in the macular region followed by panretinal photocoagulation. Despite the laser treatment, there was a rapid progression to severe proliferative retinopathy and vitreoretinal traction within 6 months (Fig. 1E), which necessitated bilateral vitreo-retinal surgery. After the laser and surgical treatment (Fig. 1F), visual acuity stabilized at 0.8 in both eyes. Case 2 is a 29-year-old man who has had diabetes since he was 13 years old. He was poorly regulated over the years, and his HbA1c was around 10– 12%, apart from a shorter period when levels went from 12.3% to 6.4% in 2 months and back to 10.4% after another 3 months. Progression from mild to moderate retinopathy with microaneurysms, haemorrhages, and cotton wool spots (most pronounced in the left eye; Fig. 2A) occurred between two regular photographic screening controls performed 1 year apart, and this change coincided with the improved metabolic control. As in case 1, the angiogram revealed irregularly dilated vessels and diffuse leakage in the macular region (Fig. 2B), although the vessel abnormalities and ischemia were more pronounced in the mid-periphery (Fig. 2C). Both eyes were treated with focal ⁄ grid photocoagulation in the macular region followed by panretinal photocoagulation. Despite laser treatment, proliferative Acta Ophthalmologica 2010

Preliminary Study on Radioluminescence Dose Rate Measurement of Α-Al 2O 3:C Coupled to SiPM

Studies on Radioluminescence Dose-Rate Measurement Based on LiF:Mg,Ti and SiPM

Dosimetry of ultra-high dose rate electron beams using thermoluminescence and optically stimulated luminescence detectors

Gamma dose rate monitoring using a Silicon Photomultiplier-based plastic scintillation detector

New liquid scintillation counter development using Silicon Photomultipliers

Simulations Research on the Dosimetry Characteristics of the α-Al2O3:C Crystal Optically Stimulated Luminescent by Monte Carlo

A Novel Measurement Method for SiPM External Crosstalk Probability at Low Temperature

Optically stimulated luminescence and thermoluminescence efficiencies for high-energy heavy charged particle irradiation in Al2O3:C

Low energy alpha particles dose mapping with a combination of CR-39 detector and a high resolution flatbed scanner

Design and commissioning of a Silicon Photomultiplier-based dosimeter for Low Dose Rate (LDR) oncological brachytherapy

Scintillation detectors constructed with an optimized 2x2 silicon photomultiplier array

Estimation of alpha exposure on CR-39 detector using a UV-VIS spectrophotometer

A Real-Time Energy Response Correction Method for Cs3Cu2I5:Tl Scintillating Dosimeter

Dosimetry of microbeam radiotherapy by flexible hydrogenated amorphous silicon detectors

Thermoluminescent characteristics of LiF:Mg,Cu,P and CaSO$_4$:Dy for low dose measurement

OSL and PTOSL of dosimetric materials: Observation of the luminescence after exposure to 90 Sr+ 90 Y source and LEDs in ultraviolet range

State-of-the-art silicon carbide diode dosimeters for ultra-high dose-per-pulse radiation at FLASH radiotherapy

Human coccidiosis in South Carolina.

Rapid, bloody, and blinding diabetic retinopathy

An Active Dose Measurement Device for Ultra-short, Ultra-intense Laser Facilities